BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18360571)

  • 21. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1.
    Machelska H; Mousa SA; Brack A; Schopohl JK; Rittner HL; Schafer M; Stein C
    J Neurosci; 2002 Jul; 22(13):5588-96. PubMed ID: 12097510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain.
    Labuz D; Berger S; Mousa SA; Zöllner C; Rittner HL; Shaqura MA; Segovia-Silvestre T; Przewlocka B; Stein C; Machelska H
    J Neurosci; 2006 Apr; 26(16):4350-8. PubMed ID: 16624955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte-derived opioid peptides and inhibition of pain.
    Machelska H; Stein C
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):90-7. PubMed ID: 18040794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioids in chronic pain.
    Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte opioid receptors mediate analgesia via Ca(2+)-regulated release of opioid peptides.
    Celik MÖ; Labuz D; Henning K; Busch-Dienstfertig M; Gaveriaux-Ruff C; Kieffer BL; Zimmer A; Machelska H
    Brain Behav Immun; 2016 Oct; 57():227-242. PubMed ID: 27139929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune cell-mediated opioid analgesia.
    Machelska H; Celik MÖ
    Immunol Lett; 2020 Nov; 227():48-59. PubMed ID: 32814155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-Irradiation of blood by gallium aluminum arsenide (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats.
    Hagiwara S; Iwasaka H; Hasegawa A; Noguchi T
    Anesth Analg; 2008 Sep; 107(3):1058-63. PubMed ID: 18713929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats.
    Hagiwara S; Iwasaka H; Okuda K; Noguchi T
    Lasers Surg Med; 2007 Dec; 39(10):797-802. PubMed ID: 18081143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue.
    Binder W; Mousa SA; Sitte N; Kaiser M; Stein C; Schäfer M
    Eur J Neurosci; 2004 Jul; 20(1):92-100. PubMed ID: 15245482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological correlates of immune-mediated peripheral opioid analgesia.
    Mousa SA
    Adv Exp Med Biol; 2003; 521():77-87. PubMed ID: 12617566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain.
    Mousa SA; Bopaiah PC; Stein C; Schäfer M
    Pain; 2003 Dec; 106(3):297-307. PubMed ID: 14659512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells.
    Brack A; Rittner HL; Machelska H; Leder K; Mousa SA; Schäfer M; Stein C
    Pain; 2004 Dec; 112(3):229-238. PubMed ID: 15561377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral opioid analgesia.
    Janson W; Stein C
    Curr Pharm Biotechnol; 2003 Aug; 4(4):270-4. PubMed ID: 14529429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocytes in the regulation of pain and analgesia.
    Rittner HL; Machelska H; Stein C
    J Leukoc Biol; 2005 Dec; 78(6):1215-22. PubMed ID: 16204636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
    Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroimmune Interaction in the Regulation of Peripheral Opioid-Mediated Analgesia in Inflammation.
    Hua S
    Front Immunol; 2016; 7():293. PubMed ID: 27532001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor in antinociception and inflammation.
    Schäfer M; Mousa SA; Stein C
    Eur J Pharmacol; 1997 Mar; 323(1):1-10. PubMed ID: 9105870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune cell-derived opioids protect against neuropathic pain in mice.
    Labuz D; Schmidt Y; Schreiter A; Rittner HL; Mousa SA; Machelska H
    J Clin Invest; 2009 Feb; 119(2):278-86. PubMed ID: 19139563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception.
    Rittner HL; Lux C; Labuz D; Mousa SA; Schäfer M; Stein C; Brack A
    Anesthesiology; 2007 Dec; 107(6):1009-17. PubMed ID: 18043070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.